Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 32 | 7 |
| Accounts receivable | -671 | -42 |
| Accounts payable and accrued liabilities | 482 | 120 |
| Other Working Capital | -364 | 43 |
| Other Operating Activity | 762 | -153 |
| Operating Cash Flow | $241 | $-26 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -64 | -36 |
| Purchase Of Investment | -10,664 | N/A |
| Other Investing Activity | -850 | 0 |
| Investing Cash Flow | $-11,579 | $-36 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 2,500 | 2,500 |
| Debt Repayment | -2,500 | -450 |
| Common Stock Repurchased | -450 | N/A |
| Other Financing Activity | 246,294 | 73,461 |
| Financing Cash Flow | $245,844 | $75,511 |
| End Cash Position | 234,507 | 75,449 |
| Net Cash Flow | $234,507 | $75,449 |
| Free Cash Flow | ||
| Operating Cash Flow | 241 | -26 |
| Capital Expenditure | -64 | -36 |
| Free Cash Flow | 177 | -62 |